
Auris Health
Total Raised
$733.29MInvestors Count
10Deal Terms
5Investments
1Auris Health Funding, Auris Health Valuation & Auris Health Revenue
7 Fundings
Auris Health's latest funding round was a Acquired for on February 13, 2019.
Auris Health's valuation in August 2017 was $1,280M.
Auris Health's latest post-money valuation is from February 2019.
Sign up for a free trial to see Auris Health's valuations in February 2019, September 2015 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
---|---|---|---|---|---|---|
2/13/2019 | Acquired | 7 | ||||
11/28/2018 | Series E | |||||
8/4/2017 | Series D | $1,280M | ||||
8/9/2016 | Series C | |||||
9/23/2015 | Series B |
Date | 2/13/2019 | 11/28/2018 | 8/4/2017 | 8/9/2016 | 9/23/2015 |
---|---|---|---|---|---|
Round | Acquired | Series E | Series D | Series C | Series B |
Amount | |||||
Investors | |||||
Valuation | $1,280M | ||||
Revenue | |||||
Sources | 7 |
Auris Health Deal Terms
5 Deal Terms
Auris Health's deal structure is available for 5 funding rounds, including their Acquired from February 13, 2019.
Round | Acquired | Series D | Series C | Series B | Series A |
---|---|---|---|---|---|
Funding Date | |||||
Pre-Money Valuation | |||||
Post-Money Valuation | |||||
Amount Raised | |||||
Shares Authorized | |||||
Issuance Price | |||||
Dividend Rate | |||||
Liquidation Preferences | |||||
Liquidation Price | |||||
Participation | |||||
Conversion Price | |||||
Anti Dilution | |||||
General Voting | |||||
Board Voting | |||||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acquired | |||||||||||||||
Series D | |||||||||||||||
Series C | |||||||||||||||
Series B | |||||||||||||||
Series A |
Auris Health Investors
10 Investors
Auris Health has 10 investors. Johnson & Johnson invested in Auris Health's Acquired funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
---|---|---|---|---|---|---|
2/13/2019 | 2/13/2019 | 1 Acquired | Corporation | New Jersey | ||
3/31/2014 | 11/28/2018 | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | Venture Capital | Texas | ||
3/31/2014 | 11/28/2018 | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | Venture Capital | New York | ||
Asset/Investment Management | Massachusetts | |||||
Venture Capital | California |
First funding | 2/13/2019 | 3/31/2014 | 3/31/2014 | ||
---|---|---|---|---|---|
Last Funding | 2/13/2019 | 11/28/2018 | 11/28/2018 | ||
Investor | |||||
Rounds | 1 Acquired | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | 5 Series A, Series B (2015), Series C (2016), Series D (2017), Series E (2018) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Asset/Investment Management | Venture Capital |
Location | New Jersey | Texas | New York | Massachusetts | California |
Auris Health Acquisitions
1 Acquisition
Auris Health acquired 1 company. Their latest acquisition was Hansen Medical on April 20, 2016.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
4/20/2016 | Other Venture Capital | $57.8M | Acquired | 5 |
Date | 4/20/2016 |
---|---|
Investment Stage | Other Venture Capital |
Companies | |
Valuation | |
Total Funding | $57.8M |
Note | Acquired |
Sources | 5 |
Auris Health Investments
1 Investments
Auris Health has made 1 investments. Their latest investment was in Qool Therapeutics as part of their Series B on November 11, 2017.
Auris Health Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
11/8/2017 | Series B | Qool Therapeutics | $13.96M | Yes | 1 |
Date | 11/8/2017 |
---|---|
Round | Series B |
Company | Qool Therapeutics |
Amount | $13.96M |
New? | Yes |
Co-Investors | |
Sources | 1 |
You May Also Like
Medrobotics has developed a platform of flexible medical robots that enable surgeons to access, visualize, and perform two-handed surgery in hard-to-reach anatomical places through a single-site access. The core technology is a new generation of flexible robotic snakes with advanced vision systems that are able to navigate tortuous paths while providing accessory channels for a wide range of flexible surgical tools. The robots are self-supporting, which means they are able to support their own weight and move within any three-dimensional space without the need for any other structural support. The company was formerly known as Cardiorobotics and Innvoention Technologies.

CMR Surgical is a surgical robotics company developing universal robotic systems for minimal access surgery. The company's vision is to make minimal access (or keyhole) surgery universally accessible and affordable by significantly expanding the range of procedures that can be performed robotically.
Activ is a developer of software to augment surgeons. It develops an AI/ML platform called ActivEdge, which is designed to provide real-time intelligence and visualization to surgeons. The company was founded in 2017 and is based in Boston, Massachusetts.

Quantum Surgical is a surgical robotics start-up building next-generation smart tools for minimally invasive therapies, beginning with interventional oncology. The robotic platform will enable physicians to better assess, plan, and treat a broad spectrum of medical conditions. The Company is developing end-to-end solutions for interventional oncology.
Intuitive Surgical develops, manufactures and markets robotic surgical systems under the da Vinci Surgical brand.

Theator offers an online platform where surgeons can record surgeries and use them as educational material for improving future procedures. It was founded in 2018 and is based in Palo Alto, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.